FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200159251> ?p ?o ?g. }

• W4200159251 endingPage "334" @default.
• W4200159251 startingPage "324" @default.
• W4200159251 abstract "Because of the negative impact of cancer treatment on female sexual function, effective treatments are warranted. The purpose of this multisite study was to evaluate the ability of two dose levels of extended-release bupropion, a dopaminergic agent, to improve sexual desire more than placebo at 9 weeks, measured by the desire subscale of the Female Sexual Function Index (FSFI), and to evaluate associated toxicities.Postmenopausal women diagnosed with breast or gynecologic cancer and low baseline FSFI desire scores (< 3.3), who had completed definitive cancer therapy, were eligible. Women were randomly assigned to receive 150 mg or 300 mg once daily of extended-release bupropion or a matching placebo. t-tests were performed on the FSFI desire subscale to evaluate whether there was a significantly greater change from baseline to 9 weeks between placebo and each bupropion arm as the primary end point. Sixty-two patients per arm provided 80% power using a one-sided t-test.Two hundred thirty women were randomly assigned from 72 institutions through the NRG Oncology NCORP network. At 9 weeks, there were no statistically significant differences in change of the desire subscale scores between groups; participants in all three arms reported improvement. The mean changes for each arm were placebo 0.62 (standard deviation [SD] = 1.18), 150-mg once daily bupropion 0.64 (SD = 0.95), and 300-mg once daily bupropion 0.60 (SD = 0.89). Total and subscale scores on the FSFI were low throughout the study, indicating dysfunction in all groups.Bupropion was not more effective than placebo in improving the desire subscale of the FSFI. Subscale and total scores of the FSFI demonstrated dysfunction throughout the 9 weeks of the study. More research is needed to support sexual function in female cancer survivors." @default.
• W4200159251 created "2021-12-31" @default.
• W4200159251 creator A5019216768 @default.
• W4200159251 creator A5020025546 @default.
• W4200159251 creator A5023914087 @default.
• W4200159251 creator A5028864875 @default.
• W4200159251 creator A5030811708 @default.
• W4200159251 creator A5033848572 @default.
• W4200159251 creator A5036433314 @default.
• W4200159251 creator A5039867739 @default.
• W4200159251 creator A5045354891 @default.
• W4200159251 creator A5047155663 @default.
• W4200159251 creator A5054640351 @default.
• W4200159251 creator A5075299871 @default.
• W4200159251 creator A5080228314 @default.
• W4200159251 creator A5081380566 @default.
• W4200159251 creator A5083156203 @default.
• W4200159251 creator A5089586569 @default.
• W4200159251 creator A5089919693 @default.
• W4200159251 date "2022-02-01" @default.
• W4200159251 modified "2023-10-16" @default.
• W4200159251 title "Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004" @default.
• W4200159251 cites W1501573778 @default.
• W4200159251 cites W1600720583 @default.
• W4200159251 cites W1831253374 @default.
• W4200159251 cites W1917007897 @default.
• W4200159251 cites W1982880546 @default.
• W4200159251 cites W1992034788 @default.
• W4200159251 cites W2019466301 @default.
• W4200159251 cites W2025002838 @default.
• W4200159251 cites W2045596828 @default.
• W4200159251 cites W2054613715 @default.
• W4200159251 cites W2058806920 @default.
• W4200159251 cites W2067814588 @default.
• W4200159251 cites W2069294139 @default.
• W4200159251 cites W2069604660 @default.
• W4200159251 cites W2075073880 @default.
• W4200159251 cites W2075234898 @default.
• W4200159251 cites W2090105521 @default.
• W4200159251 cites W2091572376 @default.
• W4200159251 cites W2114974973 @default.
• W4200159251 cites W2120385927 @default.
• W4200159251 cites W2130191718 @default.
• W4200159251 cites W2133933813 @default.
• W4200159251 cites W2134932313 @default.
• W4200159251 cites W2145911019 @default.
• W4200159251 cites W2154632051 @default.
• W4200159251 cites W2158899784 @default.
• W4200159251 cites W2159917742 @default.
• W4200159251 cites W2162420979 @default.
• W4200159251 cites W2162980337 @default.
• W4200159251 cites W2171419938 @default.
• W4200159251 cites W2227626307 @default.
• W4200159251 cites W2411274498 @default.
• W4200159251 cites W2606424315 @default.
• W4200159251 cites W2620957078 @default.
• W4200159251 cites W2724666993 @default.
• W4200159251 cites W2753057780 @default.
• W4200159251 cites W2789855405 @default.
• W4200159251 cites W2899180881 @default.
• W4200159251 cites W2899510524 @default.
• W4200159251 cites W2940780087 @default.
• W4200159251 cites W2986930155 @default.
• W4200159251 cites W4239140289 @default.
• W4200159251 doi "https://doi.org/10.1200/jco.21.01473" @default.
• W4200159251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34882500" @default.
• W4200159251 hasPublicationYear "2022" @default.
• W4200159251 type Work @default.
• W4200159251 citedByCount "8" @default.
• W4200159251 countsByYear W42001592512022 @default.
• W4200159251 countsByYear W42001592512023 @default.
• W4200159251 crossrefType "journal-article" @default.
• W4200159251 hasAuthorship W4200159251A5019216768 @default.
• W4200159251 hasAuthorship W4200159251A5020025546 @default.
• W4200159251 hasAuthorship W4200159251A5023914087 @default.
• W4200159251 hasAuthorship W4200159251A5028864875 @default.
• W4200159251 hasAuthorship W4200159251A5030811708 @default.
• W4200159251 hasAuthorship W4200159251A5033848572 @default.
• W4200159251 hasAuthorship W4200159251A5036433314 @default.
• W4200159251 hasAuthorship W4200159251A5039867739 @default.
• W4200159251 hasAuthorship W4200159251A5045354891 @default.
• W4200159251 hasAuthorship W4200159251A5047155663 @default.
• W4200159251 hasAuthorship W4200159251A5054640351 @default.
• W4200159251 hasAuthorship W4200159251A5075299871 @default.
• W4200159251 hasAuthorship W4200159251A5080228314 @default.
• W4200159251 hasAuthorship W4200159251A5081380566 @default.
• W4200159251 hasAuthorship W4200159251A5083156203 @default.
• W4200159251 hasAuthorship W4200159251A5089586569 @default.
• W4200159251 hasAuthorship W4200159251A5089919693 @default.
• W4200159251 hasBestOaLocation W42001592512 @default.
• W4200159251 hasConcept C126322002 @default.
• W4200159251 hasConcept C142724271 @default.
• W4200159251 hasConcept C168563851 @default.
• W4200159251 hasConcept C204787440 @default.
• W4200159251 hasConcept C27081682 @default.
• W4200159251 hasConcept C2775871022 @default.
• W4200159251 hasConcept C2777843972 @default.
• W4200159251 hasConcept C2779908668 @default.

• next